CN Patent

CN121752588A — 编码vegf多肽的环状rna、制剂和使用方法

Assigned to Shanghai Huanma Biopharmaceutical Co ltd · Expires 2026-03-27 · 0y expired

What this patent protects

本文公开了具有编码VEGF多肽的环状RNA的免疫原性组合物。本文还提供了相关的制造方法及其治疗用途。

USPTO Abstract

本文公开了具有编码VEGF多肽的环状RNA的免疫原性组合物。本文还提供了相关的制造方法及其治疗用途。

Drugs covered by this patent

Onpattro (PATISIRAN SODIUM) · Alnylam Pharmaceuticals

Patent Metadata

Patent number: CN121752588A
Jurisdiction: CN
Classification: —
Expires: 2026-03-27
Drug substance claim: No
Drug product claim: No
Assignee: Shanghai Huanma Biopharmaceutical Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.